$GMAB
Genmab A/S ADS
XNAS•Health Care•Pharmaceutical Preparations
$34.53
▲+0.39%+$0.135
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is GMAB up today? It is at $34.53 (+0.39%), and our scanner flagged it 50 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GMAB spikes, and full due diligence on GMAB — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $GMAB 50 times in the last 30 days. Create a free account to track $GMAB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
GMAB is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on GMAB today, peaking at 16.6x its normal volume.
Latest filing6-KForeign issuer report (6-K)Sep 9, 2026 · 8 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
GMAB is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on GMAB today, peaking at 16.6x its normal volume.
GMAB last traded at $34.53, up 0.39% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Genmab A/S ADS (GMAB) is next expected to report earnings on Thursday, November 5, 2026, about 49 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The GMAB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GMAB 50 times in the last 30 days.
GMAB (Genmab A/S ADS) trades on XNAS, with a market cap of about $21.46B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GMAB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$GMAB discussion
Sign in to ask a question or join the discussion.